Evidence map›Paper›PMID 28747198›Full record

ArticleBMC public health2017

Population-based prevalence survey of follicular trachoma and trachomatous trichiasis in the Casamance region of Senegal.

Emma M Harding-Esch, Julbert Kadimpeul, Boubacar Sarr, Awa Sane, Souleymane Badji, Mass Laye, Ansumana Sillah, Sarah E Burr, David MacLeod, Anna R Last and 3 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in BMC public health, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Prevalence of Active Trachoma and Associated Factors in Areka Town, South Ethiopia, 2018.Interdisciplinary perspectives on infectious diseases · 2020
    Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 3 countries.

Emma M Harding-EschDepartment of Clinical Research, London School of Hygiene & Tropical Medicine, London, UK. eharding@sgul.ac.uk.
Julbert KadimpeulProgramme National de Lutte Contre la Cécité, Ministère de la Sante, Dakar, Sénégal.
Boubacar SarrProgramme National de Lutte Contre la Cécité, Ministère de la Sante, Dakar, Sénégal.
Awa SaneProgramme National de Lutte Contre la Cécité, Ministère de la Sante, Dakar, Sénégal.
Souleymane BadjiProgramme National de Lutte Contre la Cécité, Ministère de la Sante, Dakar, Sénégal.
Mass LayeNational Eye Health Programme, Ministry of Health and Social Welfare, Kanifing, Gambia.
Ansumana SillahNational Eye Health Programme, Ministry of Health and Social Welfare, Kanifing, Gambia.
Sarah E BurrDepartment of Clinical Research, London School of Hygiene & Tropical Medicine, London, UK.
David MacLeodDepartment of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.
Anna R LastDepartment of Clinical Research, London School of Hygiene & Tropical Medicine, London, UK.
Martin J HollandDepartment of Clinical Research, London School of Hygiene & Tropical Medicine, London, UK.
David C MabeyDepartment of Clinical Research, London School of Hygiene & Tropical Medicine, London, UK.
Robin L BaileyDepartment of Clinical Research, London School of Hygiene & Tropical Medicine, London, UK.
London School of Hygiene & Tropical Medicine · GBMinistère de la Santé · LUMinistry of Health and Social Welfare · GM

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTrachoma, caused by ocular infection with Chlamydia trachomatis, is the leading infectious cause of blindness worldwide. We conducted the first population-based trachoma prevalence survey in the Casamance region of Senegal to enable the Senegalese National Eye Care Programme (NECP) to plan its trachoma control activities. The World Health Organization (WHO) guidelines state that any individual with trachomatous trichiasis (TT) should be offered surgery, but that surgery should be prioritised where the prevalence is >0.1%, and that districts and communities with a trachomatous inflammation, follicular (TF) prevalence of ≥10% in 1-9 year-olds should receive mass antibiotic treatment annually for a minimum of three years, along with hygiene promotion and environmental improvement, before re-assessing the prevalence to determine whether treatment can be discontinued (when TF prevalence in 1-9 year-olds falls <5%).

methodsLocal healthcare workers conducted a population-based household survey in four districts of the Bignona Department of Casamance region to estimate the prevalence of TF in 1-9 year-olds, and TT in ≥15 year-olds. Children's facial cleanliness (ocular and/or nasal discharge, dirt on the face, flies on the face) was measured at time of examination. Risk factor questionnaires were completed at the household level.

resultsSixty communities participated with a total censused population of 5580 individuals. The cluster-, age- and sex-adjusted estimated prevalence of TF in 1-9 year-olds was 2.5% (95% Confidence Interval (CI) 1.8-3.6) (38/1425) at the regional level and <5% in all districts, although the upper 95%CI exceeded 5% in all but one district. The prevalence of TT in those aged ≥15 years was estimated to be 1.4% (95%CI 1.0-1.9) (40/2744) at the regional level and >1% in all districts.

conclusionWith a prevalence <5%, TF does not appear to be a significant public health problem in this region. However, TF monitoring and surveillance at sub-district level will be required to ensure that elimination targets are sustained and that TF does not re-emerge as a public health problem. TT surgery remains the priority for trachoma elimination efforts in the region, with an estimated 1819 TT surgeries to conduct.

Indexed as

AdolescentAnti-Bacterial AgentsChildChild, PreschoolCross-Sectional StudiesDrug Administration ScheduleFemaleHealth PromotionHumansInfantInfant, NewbornMalePrevalencePublic HealthRisk FactorsSenegalAnti-Bacterial AgentsActive trachomaChlamydia trachomatisControlSenegalSurveyTrachomatous trichiasis

Identifiers

PMID28747198
PMCPMC5530574
OpenAlexW2738316149

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.